Business Services Industry
Tekelec Enhances Test Suite for IP Telephony Networks
Business Wire, Oct 18, 2000
Business Editors/High Tech Writers
MORRISVILLE, N.C.--(BUSINESS WIRE)--Oct. 18, 2000
velOSity Platform is a Leading Next-generation Diagnostics Solution
Tekelec (Nasdaq: TKLC) has enhanced its market-leading next-generation networks test solution, velOSity(TM) IP, to provide equipment manufacturers with support for the emerging media gateway control (Megaco) H.248 media gateway control protocol.
"Tekelec has added support for the Megaco H.248 protocol to its IP telephony testing portfolio, which includes TALI (transport adapter layer interface), SCTP (stream control transmission protocol) and SIP (session initiation protocol)," explains Michael Caputo, assistant vice president of marketing for the Tekelec Network Diagnostics Division. "Tekelec continues to add diagnostic support for new and evolving protocols and currently supports more than 150 protocols and 3,500 variants. We continue to enhance our position as the leading next-generation diagnostics solution provider."
David Hammond, director of product marketing in the Tekelec Network Diagnostics Division, adds, "velOSity IP combines sophisticated diagnostic capabilities for H.248 (Megaco) IP technology with a wide variety of other signaling technologies, including wireless and SS7, for which Tekelec provides market-leading solutions. The combined technologies provide equipment vendors with test case capabilities not previously available-or even considered. As IP telephony expands rapidly, it is increasingly important that vendors have the ability to test these combined technologies."
About velOSity
Tekelec's velOSity diagnostic product family includes a high-speed platform, the i3000(TM), and advanced operating system architecture for testing existing and emerging/converging technologies. Products are specifically designed to test and verify next-generation network technologies such as signaling system 7 (SS7), including SS7 over asynchronous transfer mode (ATM), general packet radio services (GPRS), universal mobile telecommunications systems (UMTS), and IP.
About Tekelec
Tekelec is a leading developer of telecommunications signaling infrastructure, diagnostic solutions, and service applications. The company's highly reliable solutions enable telecommunications carriers and equipment suppliers to achieve the benefits of the packet-telephony revolution, while keeping service quality and feature richness intact. Tekelec's innovative solutions are widely deployed in traditional and next-generation wireline, wireless, and IP voice, data communications networks, and contact centers. Corporate headquarters are located in Calabasas, Calif., with research and development facilities and sales offices worldwide. For more information, please visit http://www.tekelec.com.
The Tekelec logo is a registered trademark of Tekelec, and i3000 and velOSity are trademarks of Tekelec. All other products are registered trademarks or trademarks of their respective companies.
- 5 Rules for Immediate Annuities
- Death in the Family: 12 Things to Do Now
- Dumbest Things You Do With Your Money
- 6 Online Networking Mistakes to Avoid
- 401(k) Mistakes to Avoid
- 5 Economic Scenarios to Keep You Up at Night
- The Real ‘Best Places to Retire’
- Best Credit Cards for You
- 12 Tough Questions to Ask Your Parents
- The Real ‘Best Colleges’
- Home Buyer Tax Credit: How to Cash In
- Why You Shouldn't Bash Cash
- 8 Phony 'Bargains' and Better Alternatives
- Danger: 3 Debit Card Scams to Avoid
- 6 Myths About Gas Mileage
- 29 Fees We Hate Most
- Quick and Easy Ways to Boost Returns
- Best Stocks to Buy Now
- Lower Your Taxes: 10 Moves to Make Now
- New Jobs: 8 Lessons from Real-Life Career Switchers
- The New Job Market: Who Wins and Who Loses?
- Health Care Reform's Public Option: Everything You Need to Know
- Volunteer Work When Unemployed: Should You Work for Free?
- Whose Recovery Is This?
- Long-Term-Care Insurance: 4 Biggest Risks to Avoid
Most Recent Business Articles
- Psyadon Pharmaceuticals, Inc. Announces Regulatory Milestones and the Initiation of a Clinical Trial of Ecopipam in Lesch-Nyhan Disease
- Emergence of “Femtomedicine” - New Frontier of Biomed Sciences - Reported at First Global Congress on Nano Medicine
- Research and Markets: Ethiopia Power Market Outlook to 2020
- Research and Markets: Orphan Drugs in Asia-Pacific: from Designation to Pricing, Funding & Market Access
- Research and Markets: Now You See It - TV Program Sponsorship & Product Placement in China
Most Recent Business Publications
Most Popular Business Articles
- 7 tips for effective listening: productive listening does not occur naturally. It requires hard work and practice - Back To Basics - effective listening is a crucial skill for internal auditors
- FHM Features Anna Benson, Baseball's Hottest Wife
- Building a DNA database: the federal government has just enacted two bills related to DNA. The first would drive the collection of DNA from all infants. The second would attempt to prevent the DNA that is collected from being misused
- America's most wanted j-o-b-s - 10 hottest employment opportunities
- Developmental sequence in small groups


